Sean A. McCarthy
2016
In 2016, Sean A. McCarthy earned a total compensation of $3M as President and Chief Executive Officer at CytomX Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $292,500 |
|---|---|
| Option Awards | $2,213,348 |
| Salary | $450,000 |
| Other | $6,528 |
| Total | $2,962,376 |
McCarthy received $2.2M in option awards, accounting for 75% of the total pay in 2016.
McCarthy also received $292.5K in non-equity incentive plan, $450K in salary and $6.5K in other compensation.
Rankings
In 2016, Sean A. McCarthy's compensation ranked 3,237th out of 14,075 executives tracked by ExecPay. In other words, McCarthy earned more than 77.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,237 out of 14,075 | 77th |
Division Manufacturing | 1,122 out of 5,489 | 80th |
Major group Chemicals And Allied Products | 330 out of 1,895 | 83rd |
Industry group Drugs | 239 out of 1,538 | 85th |
Industry Pharmaceutical Preparations | 186 out of 1,176 | 84th |
Source: SEC filing on May 9, 2017.
McCarthy's colleagues
We found three more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2016.